Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2017 1
2021 2
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean arnal c[au] (126 results)?
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial.
Östör A, Van den Bosch F, Papp K, Asnal C, Blanco R, Aelion J, Alperovich G, Lu W, Wang Z, Soliman AM, Eldred A, Barcomb L, Kivitz A. Östör A, et al. Among authors: asnal c. Ann Rheum Dis. 2022 Mar;81(3):351-358. doi: 10.1136/annrheumdis-2021-221048. Epub 2021 Nov 23. Ann Rheum Dis. 2022. PMID: 34815219 Free PMC article. Clinical Trial.
Primary Sjögren syndrome and development of another autoimmune rheumatic disease during the follow-up.
Rodríguez MF, Asnal C, Gobbi CA, Pellet ACC, Herscovich N, Amitrano C, Demarchi J, Noé DD, Segura C, Caeiro F, Riscanevo N, Saurit V, Papasidero S, Alba PB, Raiti L, Cruzat V, Santiago ML, Vélez S, Salvatierra G, Juárez V, Secco A. Rodríguez MF, et al. Among authors: asnal c. Adv Rheumatol. 2022 Jun 7;62(1):19. doi: 10.1186/s42358-022-00250-7. Adv Rheumatol. 2022. PMID: 35672809
Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Demarchi J, Papasidero S, Medina MA, Klajn D, Chaparro Del Moral R, Rillo O, Martiré V, Crespo G, Secco A, Catalan Pellet A, Amitrano C, Crow C, Asnal C, Pucci P, Caeiro F, Benzanquen N, Pirola JP, Mayer M, Zazzetti F, Velez S, Barreira J, Tamborenea N, Santiago L, Raiti L. Demarchi J, et al. Among authors: asnal c. Clin Rheumatol. 2017 Nov;36(11):2455-2460. doi: 10.1007/s10067-017-3822-3. Epub 2017 Sep 14. Clin Rheumatol. 2017. PMID: 28913747
Work productivity and activity impairment in patients with primary Sjögren's syndrome.
Bejarano MV, Romanini F, Catalán Pellet A, Mamani MN, Papasidero S, Demarchi J, Asnal CA, Crow CE, Nitsche A, Encinas L, Caeiro F, Gobbi CA, Albiero E, Gómez A, Águila Maldonado R, García M, Gallardo MA, Soriano ER, Raiti L, Salvatierra G, Eimon A, Secco A. Bejarano MV, et al. Among authors: asnal ca. Clin Exp Rheumatol. 2021 Nov-Dec;39 Suppl 133(6):93-99. doi: 10.55563/clinexprheumatol/6rd9mr. Epub 2021 Nov 10. Clin Exp Rheumatol. 2021. PMID: 34796845 Free article.
Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
Isnardi CA, Roberts K, Saurit V, Petkovic I, Báez RM, Quintana R, Tissera Y, Ornella S, D Angelo Exeni ME, Pisoni CN, Castro Coello VV, Berbotto G, Haye Salinas MJ, Velozo E, Reyes Torres ÁA, Tanten R, Zelaya MD, Gobbi C, Alonso CG, de Los Ángeles Severina M, Vivero F, Paula A, Cogo AK, Alle G, Pera M, Nieto RE, Cosatti M, Asnal C, Pereira D, Albiero JA, Savio VG, Maldonado FN, Gamba MJ, Germán NF, Baños A, Gallino Yanzi J, Gálvez Elkin MS, Morbiducci JS, Martire MV, Maldonado Ficco H, Schmid MM, Villafañe Torres JA, de Los Ángeles Correa M, Medina MA, Cusa MA, Scafati J, Agüero SE, Lloves Schenone NM, Soriano ER, Graf C, Pons-Estel BA, Gomez G, Landi M, De la Vega MC, Pons-Estel GJ; S. A. R.–COVID Registry Investigators. Isnardi CA, et al. Among authors: asnal c. Clin Rheumatol. 2023 Feb;42(2):563-578. doi: 10.1007/s10067-022-06393-8. Epub 2022 Oct 6. Clin Rheumatol. 2023. PMID: 36201124 Free PMC article.
Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study.
Bellomio V, Spindler A, Lucero E, Berman A, Santana M, Moreno C, Hidalgo RP, Paira S, Graf C, Maldonado Cocco JA, Citera G, Arriola MS, Gómez G, Barreira JC, Messina O, Asnal C, Carrillo D, Gervilla A, García L, Máscolo M, De la Sota M D, Rosso G, Somma LF, Sosa RF, Rillo O, Caracciolo JA, Lancioni G, Gómez A. Bellomio V, et al. Among authors: asnal c. Lupus. 2000;9(5):377-81. Lupus. 2000. PMID: 10878732
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial.
Östör A, Van den Bosch F, Papp K, Asnal C, Blanco R, Aelion J, Carter K, Stakias V, Lippe R, Drogaris L, Soliman AM, Chen MM, Padilla B, Kivitz A. Östör A, et al. Among authors: asnal c. Rheumatol Ther. 2024 Mar 18. doi: 10.1007/s40744-024-00657-2. Online ahead of print. Rheumatol Ther. 2024. PMID: 38498139 Free article.